Traditional Chinese Medicine Treatment for a Liver Cancer Patient: A 12-Year Follow-up Case Report
1.Center for Integrated Chinese and Western Medicine, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
DOI:
扫 描 看 全 文
LIU Yang, YANG Huasheng. Traditional Chinese Medicine Treatment for a Liver Cancer Patient: A 12-Year Follow-up Case Report[DB/OL].(2023-10-28)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43200152&Fpath=home&index=0
DOI:
LIU Yang, YANG Huasheng. Traditional Chinese Medicine Treatment for a Liver Cancer Patient: A 12-Year Follow-up Case Report[DB/OL].(2023-10-28)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=43200152&Fpath=home&index=0DOI:
Traditional Chinese Medicine Treatment for a Liver Cancer Patient: A 12-Year Follow-up Case Report
Summary of case history, The patient, male, 41 years old, was admitted to Beijing Youan Hospital for the first time in March 2011 with the chief complaint of "hepatitis B history for more than 20 years, liver cirrhosis for more than 5 years". He had a dark complexion, positive palmar erythema. Mild edema of the lower extremities, no other special symptoms. The left pulse was stringy and slippery, and the right pulse was stringy and thin. The tongue was dark purple, and the tongue coating was peeled and dry. March 10, 2011: The results of our hospital examination were: hepatitis B five items: HBsAg, HBeAg, HBcAb positive; alpha-fetoprotein: AFP 11.21ng/ml; liver function: ALT 54.5U/L, AST 66.8U/L, TBIL 52.6umol/L, ALB 34.9g/L, GGT 105.5U/L, ALP 264.6U/L, CHE 3152U/L; hepatitis B virus load: HBV-DNA 8.6×10^6IU/ml; blood routine: PLT 59×10^9/L. Upper abdominal MRI examination: high-grade atypical hyperplastic nodules (DN) under the capsule of the lateral upper segment of the left lobe of the liver and under the capsule of the posterior upper segment of the right lobe of the liver, suggesting AFP examination or (3-6 months) re-examination.,TCM diagnosis, Mass accumulation, water and blood stasis interlocking, with yin deficiency,Western medicine diagnosis, Hepatitis B cirrhosis in the compensatory stage, precancerous lesions of liver cancer, splenic hyperfunction,Therapeutic methods, In terms of western medicine treatment, we gave the patient entecavir antiviral treatment. In terms of traditional Chinese medicine treatment, we gave activating blood circulation and removing blood stasis, nourishing yin and promoting diuresis treatment, using Danggui Shaoyao Powder as the main prescription, and adding 30 grams of Chu Shi Zi, 10 grams of Safflower Seeds, 30 grams of An Lü Zi, etc. After more than 20 follow-up visits, all were given Chinese medicine combined with antiviral treatment.,Clinical outcomes, The first stage was a 14-month treatment during which the pre-cancerous lesion on the left side of the patient's liver disappeared and the pre-cancerous lesion on the right side of the liver continued to progress. In the second stage, after another 29 months, the pre-cancerous lesion on the right side of the patient's liver turned into liver cancer. The patient refused surgical treatment and only received traditional Chinese medicine anti-tumor and entecavir treatment. In the third stage, 13 months after being diagnosed with liver cancer, the tumor volume decreased. After another 16 months of treatment, an MRI of the liver suggested a decrease in tumor components. After a total of 33 months of treatment after being diagnosed with liver cancer, the tumor components disappeared.The patient has been followed up since 2011 until 2023, and currently has no tumor manifestation in the liver, and is in good general condition.
关键词
肝癌中医中药抗肿瘤乙肝
Keywords
Liver cancerTraditional Chinese medicineChinese medicineAnti-tumorHepatitis B
references
Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598-1606. doi:10.1016/j.jhep.2022.08.021http://dx.doi.org/10.1016/j.jhep.2022.08.021.
Tsai T.Y., Livneh H., Hung T.H., Lin I.H., Lu M.C., Yeh C.C., 2017. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. Bmj Open 7, e014571.
Wang X, Wang N, Cheung F, Lao L, Li C, Feng Y. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms. J Integr Med. 2015;13(3):142-164. doi:10.1016/S2095-4964(15)60171-6http://dx.doi.org/10.1016/S2095-4964(15)60171-6